Lausanne

AC Immune Announces New Clinical Results in Down Syndrome and Plans for Future Development of Anti-Amyloid-Beta Vaccine

Retrieved on: 
Tuesday, March 16, 2021
Medical specialties, Vaccination, Vaccine, Virology, Medicine, Health sciences, Vaccines, Medical research, Hypothetical technology

Specifically, we are advancing our anti-Abeta vaccine, which demonstrated encouraging results in a first-of-its-kind Phase 1b study in people with DS.

Key Points: 
  • Specifically, we are advancing our anti-Abeta vaccine, which demonstrated encouraging results in a first-of-its-kind Phase 1b study in people with DS.
  • Importantly, the successful completion of this study demonstrates the feasibility of safely testing our Abeta vaccine in individuals with DS.
  • We look forward to continuing clinical development in order to potentially offer an effective vaccine strategy to treat, and perhaps ultimately prevent, the development of AD in individuals with DS.
  • This allows us to focus our in-house efforts on advancing our vaccine into later-stage clinical development to address genetically defined AD in people with DS.

 ADC Therapeutics to Host Fourth Quarter and Year-End 2020 Financial Results Conference Call on March 18, 2021

Retrieved on: 
Thursday, March 11, 2021
Biotechnology, Pharmaceutical, Health, Oncology, Subdivisions of Switzerland, Cantons of Switzerland, Canton of Vaud, Lausanne, Suisse romande

ET to report financial results for the fourth quarter and year-end 2020 and provide business updates.

Key Points: 
  • ET to report financial results for the fourth quarter and year-end 2020 and provide business updates.
  • To access the live call, please dial 833-303-1198 (domestic) or +1-914-987-7415 (international) and provide conference ID 4985202.
  • A live webcast of the presentation will be available under Events and Presentations in the Investors section of the ADC Therapeutics website at ir.adctherapeutics.com .
  • ADC Therapeutics is based in Lausanne (Biople), Switzerland and has operations in London, the San Francisco Bay Area and New Jersey.

AC Immune Presents New Preclinical Data for Therapeutic and Diagnostic Candidates Addressing Novel Targets for Neurodegenerative Diseases

Retrieved on: 
Tuesday, March 9, 2021
Life sciences, Biotechnology, Biology, Pathology, Biopharmaceutical

Together the presentations further illustrate the synergy between AC Immunes SupraAntigenand Morphomertechnology platforms to deliver a precision medicine approach to treating neurodegenerative diseases (NDD).

Key Points: 
  • Together the presentations further illustrate the synergy between AC Immunes SupraAntigenand Morphomertechnology platforms to deliver a precision medicine approach to treating neurodegenerative diseases (NDD).
  • AC Immune targets pathological forms of these proteins with highly specific antibody and small molecule therapeutics, as well as first-in-class positron emission tomography (PET) diagnostic candidates, which are amongst the most advanced in the field.
  • AC Immune SA is a Nasdaq-listed clinical-stage biopharmaceutical company, which aims to become a global leader in precision medicine for neurodegenerative diseases.
  • The Company's pipeline features nine therapeutic and three diagnostic product candidates, with six currently in clinical trials.

US Sports Camps Announces Esporterz Gaming Facility as New Northern California Camp Location

Retrieved on: 
Thursday, March 4, 2021
Companies, Lausanne, Logitech, US Sports Camps, eSports, Gaming, Economy of Switzerland

Esporterz will also be hosting an Esports Camps' Girls in Gaming event.

Key Points: 
  • Esporterz will also be hosting an Esports Camps' Girls in Gaming event.
  • Esporterz founder, Nadia Berkowitz, will be overseeing the new Marin camp location.
  • US Sports Camps (USSC), headquartered in San Rafael, California, is America's largest sports camp network.
  • Esporterz is Marin County's premiere state-of-the-art gaming center, equipped with custom gaming PC's, Logitech Pro peripherals, 240Hz & 144Hz monitors, high-performance Vertagear gaming chairs, and a dedicated high-speed fiber connection.

Premier LogiTech Named to SMU Cox Dallas 100™ List of DFW’s Fastest Growing Private Companies

Retrieved on: 
Thursday, March 4, 2021
Data management, Technology, Transport, Logistics, Supply chain management, Software, Other Transport, Companies, Lausanne, Logitech, Dallas–Fort Worth metroplex, Cox School of Business, Dallas, Southern Methodist University, Geography of Texas, The Dallas 100 Entrepreneur Awards, Premier LogiTech

Premier LogiTech is proud to announce their inclusion on the SMU Cox School of Business list of the fastest growing independent, privately held companies in Dallas-Fort Worth.

Key Points: 
  • Premier LogiTech is proud to announce their inclusion on the SMU Cox School of Business list of the fastest growing independent, privately held companies in Dallas-Fort Worth.
  • We are pleased to be included on this prestigious list as #58 of the fastest growing companies in the area, added Scott Paul, President and CEO.
  • Co-founded by the Caruth Institute for Entrepreneurship in 1990, the Dallas 100 Awards is an annual event that identifies and honors the 100 fastest-growing privately held companies in the Dallas area.
  • For more information on The Dallas 100, visit http://www.smu.edu/Cox/CentersAndInstitutes/CaruthInstituteForEntreprene...
    Premier LogiTech is an award-winning services and solutions provider of logistics and technology.

CLG and Logitech G Announce Marketing Partnership

Retrieved on: 
Monday, March 1, 2021
General Sports, Sports, Marketing, Communications, General Entertainment, Events, Concerts, Electronic Games, Entertainment, Companies, Lausanne, Logitech, Computer peripherals, Economy of Switzerland, Streamlabs, CLG, LGS

CLG, a top-tier North American esports organization, and Logitech G, a leading innovator in gaming technologies and gear, have announced a multi-year partnership that names Logitech G the Official Peripherals Partner for CLG Red, which includes CLGs CS:GO Team, and female players and content creators in Valorant and Chess.

Key Points: 
  • CLG, a top-tier North American esports organization, and Logitech G, a leading innovator in gaming technologies and gear, have announced a multi-year partnership that names Logitech G the Official Peripherals Partner for CLG Red, which includes CLGs CS:GO Team, and female players and content creators in Valorant and Chess.
  • Logitech G will play a key role in marketing elements for CLG Red and be featured on all CLG Red jerseys, throughout broadcasts of competitions and across all of the team digital channels.
  • As a part of this partnership, Logitech G will receive brand integration throughout each CLG Red broadcast, play an active role in broadcast marketing materials and have the opportunity to conduct in-broadcast sweepstakes and additional promotions.
  • Brands of Logitech include Logitech , Logitech G , ASTRO Gaming , Streamlabs , Blue Microphones , Ultimate Ears and Jaybird .

Logitech Increases Fiscal Year 2021 Outlook, Raises Long-Term Financial Model

Retrieved on: 
Monday, March 1, 2021
Hardware, Audio, Video, Consumer electronics, Technology, Software, Companies, Logitech, Lausanne, Nasdaq, Inc., Economy of Switzerland

Were delivering an extremely strong fiscal year, said Bracken Darrell, Logitech president and chief executive officer.

Key Points: 
  • Were delivering an extremely strong fiscal year, said Bracken Darrell, Logitech president and chief executive officer.
  • These trends have accelerated over the course of the fiscal year and have seen a coming of age for Logitech.
  • Brands of Logitech include Logitech , Logitech G , ASTRO Gaming , Streamlabs , Blue Microphones , Ultimate Ears and Jaybird .
  • Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A and/or its affiliates in the U.S. and other countries.

AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD™ 2021 Virtual Conference

Retrieved on: 
Wednesday, February 24, 2021
Branches of biology, Neurological disorders, Biology, Life sciences, Neurodegeneration, Neuroscience, Senescence, Eli Lilly and Company, TAR DNA-binding protein 43

The presentations will highlight preclinical results from the Companys wholly-owned therapeutic and diagnostic programs targeting pathological forms of alpha-synuclein and TAR DNA-binding protein 43 (TDP-43) for neurodegenerative diseases.

Key Points: 
  • The presentations will highlight preclinical results from the Companys wholly-owned therapeutic and diagnostic programs targeting pathological forms of alpha-synuclein and TAR DNA-binding protein 43 (TDP-43) for neurodegenerative diseases.
  • The presentations will showcase how AC Immunes expertise in discovery, assay development and characterization of promising candidates powers its industry-leading pipeline.
  • AC Immune SA is a Nasdaq-listed clinical-stage biopharmaceutical company, which aims to become a global leader in precision medicine for neurodegenerative diseases.
  • It has collaborations with major pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company and Janssen Pharmaceuticals.

DGAP-News: R-LOGITECH S.A.M. increases volume of its existing EUR 160 million 8.5% bond 2018/2023 by EUR 40 million

Retrieved on: 
Wednesday, February 17, 2021
Companies, Lausanne, Logitech, Logistics, Business, Articles

Monaco, 17 February 2021 - The board of directors of R-LOGITECH S.A.M., an international provider of port infrastructure and logistics services with its main focus on the natural resources sector, resolved today to increase its EUR 160 million 8.5% corporate bond 2018/2023 (ISIN: DE000A19WVB8) by a further EUR 40 million to a total volume of EUR 200 million.

Key Points: 
  • Monaco, 17 February 2021 - The board of directors of R-LOGITECH S.A.M., an international provider of port infrastructure and logistics services with its main focus on the natural resources sector, resolved today to increase its EUR 160 million 8.5% corporate bond 2018/2023 (ISIN: DE000A19WVB8) by a further EUR 40 million to a total volume of EUR 200 million.
  • The new notes from the tap issue will be included in the Open Market at the Frankfurt Stock Exchange under an interim ISIN DE000A3KLDG9.
  • After a period of 40 days (TEFRA-D), the tap notes will be merged with the existing notes 2018/2023.
  • R-LOGITECH is one of the leading international ports infrastructure operators and logistics services providers in the natural resources sector.

AC Immune to Highlight Promising Alzheimer’s Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference

Retrieved on: 
Wednesday, February 17, 2021
SVB Leerink, Immunogenicity, Companies

LAUSANNE, Switzerland, Feb. 17, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that it will participate in the upcoming SVB Leerink 10th Annual Global Healthcare Conference, taking place virtually on February 2226, 2021.

Key Points: 
  • LAUSANNE, Switzerland, Feb. 17, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that it will participate in the upcoming SVB Leerink 10th Annual Global Healthcare Conference, taking place virtually on February 2226, 2021.
  • During a fireside chat, AC Immune CEO Prof. Andrea Pfeifer will discuss the Companys execution strategy to advance and accelerate its precision medicine approach to targeting neurodegenerative diseases.
  • Prof. Pfeifer will also highlight AC Immunes novel anti-phospho-Tau (pTau) vaccine candidate ACI-35.030, including recent interim Phase 1b/2a results that showed promising immunogenicity and safety in patients with early Alzheimers disease.
  • AC Immune SA is a Nasdaq-listed clinical-stage biopharmaceutical company, which aims to become a global leader in precision medicine for neurodegenerative diseases.